SARS-CoV-2 Neutralizing Antibody Positive Serum

Product Description

SARS-CoV-2 Neutralizing Antibody Positive Serum
Catalog number: B2010668
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mL
Molecular Weight or Concentration: na
Supplied as: Serum
Applications: molecular tool in the research an development of SARS-CoV-2 Neutralizing antibodies assays
Storage: -20C
Keywords: Serum neutralizing antibodies, neutralizing antibodies in serum, Omicron Neutralizing antibodies
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

SARS-CoV-2 Brochure

References:
1: Barnes CO, Jette CA, Abernathy ME, Dam KA, Esswein SR, Gristick HB, Malyutin
AG, Sharaf NG, Huey-Tubman KE, Lee YE, Robbiani DF, Nussenzweig MC, West AP Jr,
Bjorkman PJ. SARS-CoV-2 neutralizing antibody structures inform therapeutic
strategies. Nature. 2020 Dec;588(7839):682-687.

2: Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, Muecksch F,
Rutkowska M, Hoffmann HH, Michailidis E, Gaebler C, Agudelo M, Cho A, Wang Z,
Gazumyan A, Cipolla M, Luchsinger L, Hillyer CD, Caskey M, Robbiani DF, Rice CM,
Nussenzweig MC, Hatziioannou T, Bieniasz PD. Escape from neutralizing antibodies
by SARS-CoV-2 spike protein variants. Elife. 2020 Oct 28;9:e61312.

3: Poeschla E. Neutralizing SARS-CoV-2. Elife. 2020 Dec 15;9:e64496.

4: Ke Z, Oton J, Qu K, Cortese M, Zila V, McKeane L, Nakane T, Zivanov J,
Neufeldt CJ, Cerikan B, Lu JM, Peukes J, Xiong X, Kräusslich HG, Scheres SHW,
Bartenschlager R, Briggs JAG. Structures and distributions of SARS-CoV-2 spike
proteins on intact virions. Nature. 2020 Dec;588(7838):498-502.

5: Garcia-Beltran WF, Lam EC, St Denis K, Nitido AD, Garcia ZH, Hauser BM,
Feldman J, Pavlovic MN, Gregory DJ, Poznansky MC, Sigal A, Schmidt AG, Iafrate
AJ, Naranbhai V, Balazs AB. Multiple SARS-CoV-2 variants escape neutralization
by vaccine-induced humoral immunity. Cell. 2021 Apr 29;184(9):2372-2383.e9.

6: Yuan M, Liu H, Wu NC, Wilson IA. Recognition of the SARS-CoV-2 receptor
binding domain by neutralizing antibodies. Biochem Biophys Res Commun. 2021 Jan
29;538:192-203.

7: Hacisuleyman E, Hale C, Saito Y, Blachere NE, Bergh M, Conlon EG, Schaefer-
Babajew DJ, DaSilva J, Muecksch F, Gaebler C, Lifton R, Nussenzweig MC,
Hatziioannou T, Bieniasz PD, Darnell RB. Vaccine Breakthrough Infections with
SARS-CoV-2 Variants. N Engl J Med. 2021 Jun 10;384(23):2212-2218.

8: Cohen SA, Kellogg C, Equils O. Neutralizing and cross-reacting antibodies:
implications for immunotherapy and SARS-CoV-2 vaccine development. Hum Vaccin
Immunother. 2021 Jan 2;17(1):84-87.

9: Pace RM, Williams JE, Järvinen KM, Belfort MB, Pace CDW, Lackey KA, Gogel AC,
Nguyen-Contant P, Kanagaiah P, Fitzgerald T, Ferri R, Young B, Rosen-Carole C,
Diaz N, Meehan CL, Caffé B, Sangster MY, Topham D, McGuire MA, Seppo A, McGuire
MK. Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in
Milk Produced by Women with COVID-19. mBio. 2021 Feb 9;12(1):e03192-20.
10: Liu J, Liu Y, Xia H, Zou J, Weaver SC, Swanson KA, Cai H, Cutler M, Cooper
D, Muik A, Jansen KU, Sahin U, Xie X, Dormitzer PR, Shi PY. BNT162b2-elicited
neutralization of B.1.617 and other SARS-CoV-2 variants. Nature. 2021
Aug;596(7871):273-275.

Products Related to SARS-CoV-2 Neutralizing Antibody Positive Serum: Antibodies